—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
CLINICAL IMMUNOLOGY《临床免疫学》
月刊 - 美国
  • CLINICAL IMMUNOLOGY《临床免疫学》
  • SCIE外文期刊
  • 期发文量11
  • 国人占比25.00%
  • 知网目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:3区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:3
    环比增速:-50.00%
  • 期刊信息

  • 研究方向:医学-IMMUNOLOGY免疫学
  • 国际刊号:ISSN 1521-6616;EISSN 1521-7035
  • 期刊语言:英语
    出版地区:美国
  • 投稿网址:https://www.editorialmanager.com/yclim/default.aspx
  • 电子邮箱:
  • 期刊官网:https://www.journals.elsevier.com/clinical-immunology/
  • 作者指南:
  • 出版商网址:https://www.elsevier.com/
  • 出版地址:525 B ST, STE 1900, SAN DIEGO, USA, CA, 92101-4495
  • 期刊简介:CLINICAL IMMUNOLOGY《临床免疫学》(月刊). Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor.Research Areas Include:• Ageing• Allergy• Autoimmunity• Biotechnology• Clinical Laboratory Immunology• HIV• Immunodermatology• Immunohematology• Immunotoxicology/Environmental• Infection and Immunity• Mucosal Immunity• Neuroimmunology• Primary Immunodeficiency• Transplantation• Tumor Immunology• Vaccines.

  • 万维提示





  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://www.journals.elsevier.com/clinical-immunology/

    https://www.sciencedirect.com/journal/clinical-immunology

    3、投稿网址:

    https://www.editorialmanager.com/yclim/default.aspx

    4、期刊刊期:月刊,一年出版12期。

    2022118日星期

                                  

     

    投稿须知【官网信息】

     

    Guide for Authors

    Clinical Immunology is an international medium devoted to publication of original investigations of the molecular and cellular basis of immunological diseases. Prospective contributors are encouraged to check recent articles published in Clinical Immunology on topics related to their manuscript to have a better understanding of the articles that the readership is interested in.

    Types of Articles

    Original Articles. The chief criteria for acceptance of papers submitted for publication are the originality, clarity, and quality of the work reported. In preparing an article for submission to Clinical Immunology, please be as concise as possible. Data should be presented clearly and without repetition. Where possible, refer to previously published material rather than including lengthy descriptions in the Materials and Methods section, combine tables or illustrations, and avoid repetition in the Introduction and Discussion sections.

    Reviews of 20 manuscript pages (double spaced or less, exclusive of references) are published monthly. Generally a maximum total of 4 figures/tables are included. Typically, they deal analytically with recent developments in basic, translational, and clinical interventional immunology of immediate interest to a broad range of clinical immunologists. Contributors are encouraged to contact Journal Article Publishing Support Hub, before undertaking a review in order to determine its suitability.

    Symposia-in-Writing. Periodically, the journal publishes a collection of brief state-of-the-art essays based on a single topic, accompanied by an introduction by the symposium's moderator. Potential moderators should contact the Editor-in-Chief or one of the Associate Editors.

    Brief articles describing and evaluating animal models of immune-mediated diseases of humans are published occasionally. Contributors should contact Journal Article Publishing Support Hub

    Rapid Communications (of no more than 3000 words and two tables and/or figures) will be considered for publication on an accelerated schedule. This category is NOT simply a place for short manuscripts but is reserved for papers that the authors feel will have unusually high impact and should be disseminated as soon as possible. The reasons for requesting a paper be considered as a Rapid Communication should be made clear in the cover letter. Rapid Communications will receive an expedited review, and reviewers will be requested to indicate only their recommendation for or against acceptance for publication, and the major reasons for this. Authors will be notified of their acceptability as early as possible. Once in production Rapid Communications will always be placed in the first available issue.

    Brief Communication (of no more than 3000 words and two tables and/or figures) will be considered for publication. This category is a place for short manuscripts that have important and generally conclusionary data on a specific issue.

    Letters to the Editor will be considered if they relate to articles published in the journal. They should be limited to 1000 words, contain no more than one figure or table, and should have no more than 10 citations.

    Editorials and Meeting Reports are published occasionally if they are directly relevant to the themes of the journal.

    Contact details for submission

    Articles for Clinical Immunology should be submitted via the journal's online submission and editorial system at https://www.editorialmanager.com/yclim/default.aspx.

    Customer support is available 24/7:

    Please use our help site at: https://service.elsevier.com/. Here you will be able to learn more about the online submission and editorial system via interactive tutorials, explore a range of problem solutions via our knowledgebase, and find answers to frequently asked questions. You will also find our 24/7 support contact details should you need any assistance from one of our customer service representatives.

    For questions on the submission and reviewing process, please contact the Editorial Office at Journal Article Publishing Support Hub.

    Submission checklist

    You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

    ……

    更多详情:

    https://www.elsevier.com/journals/clinical-immunology/1521-6616/guide-for-authors






欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码